In addition, the expression of IL1RL1 (also known as ST2 and IL33R), has been shown to be negatively associated with depression severity in post-stroke depression, whereas the expression of its ligand, the cytokine IL33, was positively associated with severity [30–33]. Here, IL33 is linked to depressive symptom measurement.